APA (7th ed.) Citation

Yuan, Y., Luo, S., Wang, X., Zheng, Z., Qi, Q., Wang, Y., . . . Wang, J. (2025). Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: A phase II multicenter clinical trial. Radiation Oncology, 20(1), 1. https://doi.org/10.1186/s13014-025-02604-z

Chicago Style (17th ed.) Citation

Yuan, Yupei, et al. "Efficacy and Safety of Concurrent Programmed Cell Death Protein 1 Inhibitor and Definitive Radiotherapy with Immunonutrition Support in Esophageal Squamous Cell Cancer: A Phase II Multicenter Clinical Trial." Radiation Oncology 20, no. 1 (2025): 1. https://doi.org/10.1186/s13014-025-02604-z.

MLA (9th ed.) Citation

Yuan, Yupei, et al. "Efficacy and Safety of Concurrent Programmed Cell Death Protein 1 Inhibitor and Definitive Radiotherapy with Immunonutrition Support in Esophageal Squamous Cell Cancer: A Phase II Multicenter Clinical Trial." Radiation Oncology, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1186/s13014-025-02604-z.